CC BY
78
Histomorphological Changes in Patients with Localized Prostate as Predictors of Disease Progression
DOI: 10.17691/stm2018.10.3.17 Received November 18, 2017
Ph.S. Bova, MD, PhD, Head of Urology, Nephrology and Hemodialysis Center1; A.Yu. Maksimov, MD, DSc, Professor, Deputy Director2; N.S. Karnaukhov, Head of Anatomic Pathology Department2;
O.I. Kit, MD, DSc, Corresponding Member of Russian Academy of Sciences, Professor, Director
1Regional Hospital No.2, 33, 1st Konnoy Armii St., Rostov-on-Don, 344112, Russia;
2Rostov Research Institute of Oncology, 63, 14th Liniya St., Rostov-on-Don, 344037, Russia
The aim of the investigation was to study dysplastic, hyperplastic and inflammatory changes in the peritumoral zon influence on proliferative activity of tumor cells in patients with localized prostate cancer (PC) after radical prostatectomy.
Materials and Methods. Histomorphological examination of surgical tissue samples from the perifocal zone was carried out using light microscopy in 309 patients with localized PC (T1c-T2cN0M0) after radical surgery. High degree of histopathological differentiation was found in 22 patients (7.1%), moderate degree in 283 (91.6%) and low degree in 4 patients (1.3%). Serum prostate-specific antigen concentration was determined by enzyme immunoassay. Proliferative activity of tumor cells was studied using immunohistochemical examination of Ki-67 marker expression in the tumor.
Results. Histomorphological examination of the peritumoral zone made it possible to reveal histopathological processes combined with prostate adenocarcinoma in 257 of 309 (83.2%) patients with localized prostate cancer: nonspecific chronic bacterial prostatitis in 60.2% of cases, high-grade prostatic intraepithelial neoplasia (PIN-2) in 31.1%, benign hyperplastic processes including sclerosing adenosis and their combinations in 21%.
The most pronounced chronic inflammatory changes in the perifocal zone were observed when prostate adenocarcinoma was combined with PIN-2. The presence of concomitant pathology in the perifocal zone led to no statistically significant change in serum prostate-specific antigen level. Proliferative activity of tumor cells increased in patients with PC when concomitant dysplastic processes in the peritumoral zone were combined with proliferation of stromal components in the prostate gland due to chronic prostatitis and sclerosing adenosis.
Conclusion. Perifocally located PIN-1, PIN-2, chronic prostatitis and sclerosing adenosis increase tumor cell proliferation in prostate adenocarcinoma, thus proving their predictor role.
Key words: prostate cancer; prostate adenocarcinoma; peritumoral zone; chronic prostatitis; proliferative activity.
prostatic intraepithelial neoplasia; sclerosing adenosis;
Introduction
According to the official statement on cancer care in Russia for 2016, the diagnosis of prostate cancer (PC) had the minimum rate of morphological confirmation (80.2%) in Rostov region compared to the average rate (94.7%) in Russia [1]. In 2015, the rate of morphological verification for PC diagnosis was also low in 6 regions of the country, including Rostov region (82.1%) [2]. In recent years, this problematic situation in the region has led to corresponding increase in histological studies in prostate cancer, accumulation of information requiring system analysis. Studying histomorphological changes in prostate preparations obtained during surgical treatment of prostate cancer has high diagnostic value for a particular patient and good prognostic potential
Corresponding author: Philip S. Bova, е-mail: alald@inbox.ru
regarding common cancer patterns in total data analysis.
All of the above suggests significance of morphological studies in prostate cancer. Given the fact that more than half of the patients with newly verified prostate cancer diagnosis (56%) have stage I-II disease [1], specialists' efforts should be aimed at verification of localized forms of the disease and conditions preceding the development of malignant prostate tumors. Not only tumor samples are subjected to morphological examination following radical prostatectomy but also the perifocal zones of the prostate, surgical margin [3]. However, information on specific features of tissues and cells surrounding prostate adenocarcinoma (prostatic intraepithelial neoplasia (PIN), signs of sclerosing adenosis, nonspecific bacterial chronic prostatitis (CP))
is rare in the literature [4-6]. However, pathological changes in the peritumoral zone are likely to promote mutagenesis in stromal and epithelial cells, increasing the possibility of mutations and genetic instability in adjacent specific cells [7].
The concept based on the idea that environmental and microenvironmental factors play an important role in tumor emergence and development, recurrence and metastasis formation has existed since 1990. The term "microenvironment" refers to a number of factors characterizing the events within the tumor [8]. Processes occurring in the perilesional tissue of the tumor comprise the notion of "tumor environment" or "peritumoral zone" [9]. Tumor progression in prostate cancer depends on both molecular changes in epithelial cells and numerous changes in the stroma surrounding tissue and cell elements providing the necessary conditions for proliferation, migration, and invasion of cancer cells [10, 11].
Studying the relationship between chronic inflammation, fibrosis, dysplasia, hyperplasia in the peritumoral zone and proliferative potential of tumor cells may be useful for understanding the possible causes of early recurrence of malignant tumors.
The aim of the investigation was to study dysplastic, hyperplastic and inflammatory changes in the peritumoral zone and their influence on proliferative activity of tumor cells in patients with localized prostate cancer after radical prostatectomy.
Materials and Methods
The study was carried out in Urology, Nephrology and Hemodialysis Center of Regional Hospital No.2, Rostov-on-Don, in the Department of Oncourology and Anatomic Pathology Department of Rostov Research Institute of Oncology in 2015-2017.
Histomorphological examination of surgical bioptates was carried out in 309 patients with localized PC (T1c-T2cN0M0) after radical surgery. The age of patients in the general clinical group was 54-79 years (on average, 65.6±2.5 years).
Criteria for inclusion of patients in the study were as follows:
localized PC (T1c-T2c);
availability of data on the preoperative level of prostate-specific antigen (PSA);
histological examination of tumor and peritumoral zone samples;
no distant metastases.
The study complies with the Declaration of Helsinki (2013) and was approved by Ethics Committee of Rostov Research Institute of Oncology. Written informed consent was obtained from all patients.
Distribution of patients based on the clinical stage of PC was as follows: patients with T1c — 28 (9.1%); T2a — 33 (10.7%); T2b — 89 (28.8%); T2c — 159 (51.5%). High degree of histopathological differentiation (less than
7 Gleason scores) was found in 22 patients (7.1%), moderate degree (7 Gleason scores) in 283 (91.6%) and low degree (more than 7 Gleason scores) in 4 patients (1.3%).
After radical prostatectomy, the material obtained by the surgeon was placed in 4% buffered formalin solution and taken immediately to anatomic pathology department where it was stored no more than 24 h. For morphological examination, the pathologist formed samples of tumor tissue (minimum 3 pieces), the peritumoral zone (2 cm and more off the tumor, from both lobes of the gland) by cutting cone-shaped pieces 1.0^0.5 cm in size. Then tissue segments were cut into 15-20 slices of 0.3 mm thickness.
Microscopic examination was performed to determine the histological type of tumor, the degree of histopathological differentiation. In all patients, the histological type of tumor was represented by adenocarcinoma. Based on the results of histological examination of peritumoral bioptates, the patients were divided into subgroups with the following pathologies: PIN-2, PIN-1, benign prostatic hyperplasia (BPH), CP.
To perform histological examination by light microscopy, gland tissue slices were fixed in 10% neutral buffered formalin solution (Lilly's Formalin) with pH 7.4, then paraffin-embedded using the standard technique. Serial 3-5 ^m thick sections were deparaffinized using the standard procedure, stained with hematoxylin and eosin. The samples were examined under TOPIC-T light microscope (CETI, Netherlands).
The following histological classification of prostatitis was used in the study: mild, moderate and severe degree (the North American Chronic Prostatitis Collaborative Research Network and the International Prostatitis Collaborative Network, 2001) [12]. Moderate and severe dysplasia (PIN-2) was classified as highgrade prostatic intraepithelial neoplasia, mild dysplasia (PIN-1) — as low-grade one.
Prior to surgery, serum PSA concentration was measured in all patients by enzyme immunoassay using Multiscan P2 photometer (Thermo Fisher Scientific Inc., Finland).
Immunohistochemical examination was performed according to the standard protocol. The prepared serial sections were mounted on poly-L-lysine coated glass. Deparaffinization was carried out in a thermostat at 60°C for an hour. After immersion in xylene, the sections were rehydrated in a graded series of alcohol with decreasing concentrations for 15 min. Antigen retrieval was performed by heat-induced retrieval method in 0.01 M citrate buffer using mini-autoclave EnVision/HRP (Dako Cytomation, Denmark). Endogenous peroxidase activity was blocked using 3% hydrogen peroxide for 10 min. In this study, we used mouse monoclonal antibodies to Ki-67 protein (1:200, Diagnostic Biosystems, Spain).
Microscopic examination was performed using light microscope Axioskop 40 (Carl Zeiss, Germany); 10* eyepiece, 5*, 10*, 20*, 40*, 100* lenses. At the first
/////////////////////^^^^
140 CTM J 2018 J V0l. 10 J N0.3 Ph.S. Bova, A.Yu. Maksimov, N.S. Kamaukhov, O.I. Kit
stage, loci with the greatest number of "positive" cells were detected. The cells with unmistakable nuclei color were considered positive. Ki-67 index was calculated as the ratio of the number of cells with intense nuclear reaction to the total cell number (at least 300 cells). If Ki-67 index was less than or equal to 25%, this situation was assessed as 1 score, 26 to 50% — as 2 scores, 51 to 75% — as 3 scores and 76 to 100 % — as 4 scores [13].
Statistical data processing was performed using Statistica 10.0 (StatSoft, USA) software. Quantitative parameters were presented as mean value and standard error of the mean. Pearson's x2 test, Fisher's exact test were used to analyze the differences in proportions. Nonparametric Mann-Whitney test was used to assess the difference between the means.
Results
No histological changes in the peritumoral zone were found in 52 of 309 patients (16.8%) with localized prostate cancer. Histopathological processes combined with adenocarcinoma were observed in 257 patients (83.2%), their distribution is shown in Table 1.
Chronic inflammatory changes in the perifocal zone with clusters of lymphocytes, plasma cells, and macrophages in the stroma, reactive nuclear atypia were more common than other pathological processes (in 186 of 257, 72.4%). The proportion of severe CP increased in line PC < PC + BPH < PC + PIN-2; the proportion of moderate CP increased in line PC + PIN-2 < PC + BPH = PC; the proportion of mild CP increased in line PC + PIN-2 < PC < PC (see the Figure).
Thus, the most pronounced chronic inflammatory changes in the perifocal zone were observed when both prostate adenocarcinoma and PIN-2 were revealed.
PIN-2 came second in terms of prevalence in the
peritumoral zone: in 96 of 257 samples (37.4%). Moreover, in 27.6% (71 out of 257) of patients with localized PC, PIN-2 was detected against the background of chronic inflammatory changes in the prostate gland (see Table 1). Concomitant benign hyperplastic processes were revealed in 25.3% of cases (65 out of 257), BPH being represented by sclerosing adenosis in 11 out of 65 (17%). Microscopically, sclerosing adenosis looked like a focus of small, closely adjacent proliferating glands surrounded by a marked spindle-cell stromal component. The cytoplasm of glandular cells was scarce, acidophilic, cell nuclei were small, monomorphic, moderately colored, without
Ta bl e 1
Distribution of morphological changes in the peritumoral zone in patients with localized prostate cancer (n=257) after radical prostatectomy
Histopathological processes in the peritumoral zone Absolute % number
PIN-2 96 37.4
PIN-1 29 11.3
CP: only CP combination with other background processes 186 72.4 67 26.1 119 46.3
BPH, including sclerosing adenosis 65 25.3 11 4.3
PIN-2 + CP 71 27.6
PIN-1 + CP 8 3.1
PIN-2 + PIN-1 + CP 18 7.0
BPH + CP 40 15.6
<5
>
<D 0)
O <U CD
ro
<D
Q
100 90 80 70 60 50 40 30 20 10 0
13/40 21/67 82/186
48/71
16/40 27/67
66/186
15/71
11/40 19/67 38/186 38/186
1 8/71
PC + PIN-2 + CP
PC + BPH + CP
PC + CP
PC + CP + other processes
□ Severe
68
33
31
44
■ Moderate
21
40
40
36
Mild
11
27
29
21
Distribution of patients with prostate cancer combined with various histopathological changes in the peritumoral zone based on chronic prostatitis severity
The table shows percentages, absolute numbers are next to bar charts
cellular polymorphism. Constant presence of basal cell layer around all glands was characteristic. Amyloid corpuscles, crystalloids, occasional mitotic figures, and solid foci were observed as inconstant features.
In patients with localized PC, the presence of combined pathology in the perifocal zone led to no statistically significant change in mean serum PSA values, which required more detailed frequency analysis and comparison of proportions (Table 2).
Frequency analysis showed that the number of patients with serum PSA concentration over 21 ng/ ml was higher when PC was combined with PIN-2 and CP in the perifocal region as compared to isolated adenocarcinoma (16 vs 2% at p=0.013).
Immunohistochemical examination with antibodies to Ki-67 is conventionally used to assess proliferative
Table 2
The level of serum prostate-specific antigen in patients with localized prostate cancer and concomitant pathology (absolute number/%)
Combined Serum prostate-specific antigen (ng/ml)
histopathological processes 4-10 11-20 >21 M±m
PC without peritumoral changes (control) (n=52) 2/4 49/94 1/2 12.5±1.6
PC + PIN-2 (n=96) 1/1 90/94 5/5 12.1±1.3
PC + PIN-1 (n=29) 3/10 22/76 4/14 12.6±1.1
PC + CP (n=67) 2/3 61/91 4/6 11.9±0.9
PC + BPH (n=54) 1/2 50/93 3/5 12.2±1.0
PC + sclerosing adenosis (n=11) 0/0 10/91 1/9 12.4±0.7
PC + PIN-2 + CP (n=71) 3/4 57/80 11/16* 13.8±1.8
Note: * statistically significant difference of values with control, p=0.013 (by Fisher criterion); M — mean and m — standard error of the mean.
activity of tumor cells, including those in PC [13]. Ki-67 belongs to regulatory proteins, its expression coincides with the entry of cells into mitosis. For the largest number of patients with localized PC, Ki-67 expression was assigned 2 scores (26-50% of colored cells) regardless of combined pathology in the peritumoral zone (Table 3).
However, only when adenocarcinoma was combined with PIN-2, the number of cells with Ki-67 expression exceeded 50% and was ranked on a scale of 3 (8%) and 4 (1%) scores. When there were no changes in the perifocal zone, the score of 1 was observed less often (p<0.0001) after Ki-67 staining in patients with a combination of PC + PIN-2, the score of 2 was more frequent (p<0.0001), in 9% of cases the samples were assigned 3-4 scores, compared to the control. In combination of PC + PIN-2 + CP, the number of tumor cells expressing Ki-67 exceeded 50% (3-4 scores) in 1 0% of cases. Consequently, proliferative activity of tumor cells increased when PC occurred simultaneously with PIN-2.
The average semi-quantitative score of Ki-67 expression in tumor cells was significantly higher (p<0.05) when PC was combined with PIN-2 (2.09±0.04 scores) or PC + PIN-2 + CP (2.11±0.04 scores) as compared to isolated PC (1.60±0.07 scores), PC + PIN-1 (1.66±0.09 scores), PC + CP (1.72±0.06 scores), PC + BPH (1.78±0.06 scores) (Table 4).
Ki-67 expression score was almost similar in patients with PC + PIN-2 and PC + sclerosing adenosis.
Thus, tumor cell proliferation increases in patients with PC when concomitant dysplastic processes in the peritumoral
Ta bl e 3
Distribution of patients with prostate cancer based on the degree of Ki-67 expression in tumor cells with account of combined pathology in the peritumoral zone (absolute number/%)
Combined Ki-67 expression (scores)
histopathological processes 1 2 3 4
PC without peritumoral changes (control) (n=52) 21/40 31/60 0/0 0/0
PC + PIN-2 (n=96) 1/1 (p<0.0001) 86/90 (p<0.0001) 8/8 (p=0.05) 1/1
PC + PIN-1 (n=29) 10/34 19/66 0/0 0/0
PC + CP (n=67) 19/28 48/72 0/0 0/0
PC + BPH (n=54) 12/22 42/78 0/0 0/0
PC + sclerosing adenosis (n=11) 2/18 7/64 2/18 0/0
PC + PIN-2 + CP (n=71) 0/0 64/90 (p=0.0002) 6/9 (p=0.038) 1/1
Note: p — statistically significant difference of values with isolated prostate cancer (control).
/////////////////////^^^^
142 СТМ J 2018 J vol. 10 J No.3 Ph.S. Bova, A.Yu. Maksimov, N.S. Karnaukhov, O.I. Kit
Table 4
The score and cross-group comparative analysis of Ki-67 expression in tumor cells of patients with prostate cancer based on concomitant pathology in the peritumoral zone
No Combined M±m р between groups
histopathological processes 1 2 3 4 5 6
1 PC without peritumoral changes (control) (n=52) 1.60±0.07
2 PC + PIN-2 (n=96) 2.09±0.04 0.00007
3 PC + PIN-1 (n=29) 1.66±0.09 0.66 0.001
4 PC + CP (n=67) 1.72±0.06 0.26 0.0002 0.635
5 PC + BPH (n=54) 1.78±0.06 0.11 0.004 0.359 0.563
6 PC + sclerosing adenosis (n=11) 2.0±0.19 0.087 0.704 0.173 0.219 0.345
7 PC + PIN-2 + CP (n=71) 2.11±0.04 0.00008 0.853 0.001 0.001 0.003 0.628
zone are combined with proliferation of stromal components in the prostate gland, which is likely to affect the time of cancer recurrence later on.
Discussion
The work focuses on the results of histomorphological examination of pathological processes occurring in the perifocal zone simultaneously with prostate adenocarcinoma. It has been found that the signs of CP (72.4%), PIN-2 (37.4%) and their combinations (27.6%) are more common in the areas unaffected by the tumor. According to other authors, the combination of adenocarcinoma and PIN has been found in 40-73% of patients with verified PC during histological examination of prostate bioptates [4, 5], PC and CP — in 86.2% [14]. Certainly, the fact of detecting concomitant pathology has not been the main goal. The main thing is to know the consequences of such association for the course of the underlying disease. There are no research papers in this field, only prospective studies of consecutive relationship between background pathological processes in the gland and PC [15]. For example, chronic inflammation in the prostate gland is associated with stromal fibrosis providing the background for the development of proliferative inflammatory atrophy, a precursor to PIN and PC [16].
At present, there is evidence in the literature that the foci of proliferative inflammatory atrophy have higher proliferative activity, increased expression of Ki-67 proliferation marker as compared to the epithelium surrounding the tumor and normal epithelium [17]. Therefore, such atrophy is considered to be a variant of regeneration and the foci themselves may be called "regenerative". In terms of proliferation, they are comparable to PIN phenotype [18].
In our work, assessment of Ki-67 expression shows that the presence of PIN-2 and PIN-2 in combination with CP in the peritumoral zone is accompanied by increased
proliferative activity of adenocarcinoma cells. Sclerosing adenosis is an atypical variant of BPH. The incidence of this pathology in resection of the prostate for BPH is 2% [18]. In our study, sclerosing adenosis was found in 4.3% of cases (11 out of 257) and in 17% of all BPH cases (11 out of 65). The combination of sclerosing adenosis and PC was accompanied by increasing proliferative activity of adenocarcinoma cells compared to the control group, though the tendency failed to reach statistical significance (p=0.087). Insufficient number of cases of simultaneous PC and sclerosing adenosis in the peritumoral zone requires collecting relevant information to investigate further the relationship between features.
Conclusion
In patients with prostate cancer, it is appropriate to perform histological examination of both tumor bioptate and perifocal zone as the revealed correlation between histological changes in the peritumoral zone and proliferative activity of tumor cells is a predictor of cancer progression.
Study funding. This study was not supported by any financial sources.
Conflict of interests. The authors have no conflict of interests to disclose.
References
1. Sostoyanie onkologicheskoy pomoshchi naseleniyu rossii v 2016 godu [The state of oncological care for the population of Russia in 2016]. Pod red. Kaprina A.D., Starinskogo V.V., Petrovoy G.V. [Kaprin A.D., Starinskiy V.V., Petrova G.V. (editors)]. Moscow: MNIOI im. P.A. Gertsena; 2017; 236 p.
2. Sostoyanie onkologicheskoy pomoshchi naseleniyu rossii v 2015 godu [The state of oncological care for the population of Russia in 2015]. Pod red. Kaprina A.D., Starinskogo V.V., Petrovoy G.V. [Kaprin A.D., Starinskiy V.V.,
Petrova G.V. (editors)]. Moscow: MNIOI im. P.A. Gertsena; 2017; 236 p.
3. Lozhkin E.A., Suhanov S.A., Kiryanov N.A. New criteria of morphological assessment of the prognosis of the prostate cancer. Uralskiy meditsinskiy zhurnal 2017; 4(148): 70-72.
4. McNeal J.E. Origin and development of carcinoma in the prostate. Cancer 1969; 23(1): 24-34, https://doi.org/ 10.1002/1097-0142(196901)23:1 <24::aid-cncr2820230103> 3.0.co;2-1.
5. Bostwick D.G. Progression of prostatic intraepitelial neoplasia to early invasive adenocarcinoma. Eur Urol 1996; 30(2): 145-152, https://doi.org/10.1159/000474164.
6. Allina D.O., Andreeva Iu.Iu., Zavalishina L.E., Kekeeva T.V., Frank G.A. High-grade prostatic intraepithelial neoplasia: state-of-the-art. Arhiv patologii 2015; 77(1): 69-74.
7. Gorbunova E.N., Davydova D.A., Krupin V.N. Chronic inflammation and fibrosis as risk factors of the prostatic intraepithelial neoplasia (PIN) and prostate cancer. Sovremennye tehnologii v medicine 2011; 1: 79-83.
8. lijima J., Konno R., Itano N. Inflammatory alterations of the extracellular matrix in the tumor microenvironment. Cancers 2011; 3(3): 3189-3205, https://doi.org/10.3390/ cancers3033189.
9. Allen M., Jones L.J. Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 2011: 223(2): 162-176, https://doi.org/10.1002/path.2803.
10. Dennis L.K., Lynch C.F., Torner J.C. Epidemiologic association between prostatitis and prostate cancer. Urology 2002; 60(1): 78-83, https://doi.org/10.1016/s0090-4295(02)01637-0.
11. Corn P.G. The tumor microenvironment in prostate cancer: elucidating molecular pathways for therapy development. Cancer Manag Res 2012; 4: 183-193, https:// doi.org/10.2147/cmar.s32839.
12. Nickel J.C., True L.D., Krieger J.N., Berger R.E., Boag A.H., Young I.D. Consensus development of a
histopathological classification system for chronic prostatic inflammation. BJU Int 2001; 87(9): 797-805, https://doi. org/10.1046/j.1464-410x.2001.02193.x.
13. Kovylina M.V., Prilepskaya E.A., Sergeiko I.P., Moiseenko T.N., Kolantarev K.B., Govorov A.V., Pushkar D.Yu. Prognostic value of the immunohistochemical markers Ki-67 and p53 after radical prostatectomy. Onkourologija 2014; 1: 49-52.
14. Platz E.A., Kulac I., Barber J.R., Drake C.G., Joshu C.E., Nelson W.G., Lucia M.S., Klein E.A., Lippman S.M., Parnes H.L., Thompson I.M., Goodman P.J., Tangen C.M., De Marzo A.M. A prospective study of chronic inflammation in benign prostate tissue and risk of prostate cancer: linked PCPT and SELECT cohorts. Cancer Epidemiol Biomarkers Prev 2017; 26(10): 1549-1557, https://doi. org/10.1158/1055-9965.epi-17-0503.
15. Davidsson S., Fiorentino M., Andren O., Fang F., Mucci A., Varenhorst E., Fall K., Rider J.R. Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev 2011; 20(10): 2280-2287, https://doi. org/10.1158/1055-9965.epi-11-0373.
16. Leone A., Gershman B., Rotker K., Butler C., Fantasia J., Miller A., Afiadata A., Amin A., Zhou A., Jiang Z., Sebo T., Mega A., Schiff S., Pareek G., Golijanin D., Yates J., Karnes R.J., Renzulli J. Atypical small acinar proliferation (ASAP): is a repeat biopsy necessary ASAP? A multi-institutional review. Prostate Cancer Prostatic Dis 2016; 19(1): 68-71, https://doi.org/10.1038/pcan.2015.52.
17. Davidsson S., Carlsson J. Prostate cancer and inflammation: the role of miRNAs. EMJ Oncol 2013; 1: 56-60.
18. Kuroda N., Katto K., Ohtsuki Y., Hes O., Michal M., Inoue K., Ohara M., Mizuno K., Lee G.H. Hybrid sclerosing adenosis and basal cell hyperplasia of the prostate. Med Mol Morphol 2010; 43(4): 226-230, https://doi.org/10.1007/s00795-009-0449-8.
/тттту/ттту/тттттту/тттууттттттж 144 СТМ J 2018 Í vol. 10 Í No.3
ШШШ///////////////////^
Ph.S. Bova, A.Yu. Maksimov, N.S. Karnaukhov, O.I. Kit
